Addex Therapeutics Ltd ADXN

$ 7.9 0.51%

Annual report 2023
added 12-21-2024

Addex Therapeutics Ltd Balance Sheet 2011-2024 | ADXN

Annual Balance Sheet Addex Therapeutics Ltd

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-2.59 M	-1.42 M	-2.63 M	-1.98 M	-2.91 M	-15.3 M	-36.1 M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	274 K	286 K	288 K	309 K	373 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	1.95 M	-	639 K	244 K	214 K	196 K	145 K	490 K	789 K	1.05 M
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	5.57 M	7.5 M	2.97 M	1.72 M	1.46 M	1.23 M	1.65 M	2.85 M	5.44 M	9.78 M
Deferred Revenue	-	-	-	820 K	1.11 M	213 K	439 K	-	158	14.4 K	-	-	-
Retained Earnings	-	-	-	-314 M	-301 M	-286 M	-284 M	-281 M	-278 M	-274 M	-272 M	-256 M	-229 M
Total Assets	4.64 M	8.28 M	22.5 M	20.2 M	33 M	42.2 M	3.06 M	1.68 M	2.89 M	4 M	5.88 M	21.7 M	43.6 M
Cash and Cash Equivalents	3.87 M	6.96 M	20.5 M	18.7 M	31.5 M	41.7 M	2.58 M	-	-	-	-	-	-
Book Value	-	-	22.5 M	14.6 M	25.5 M	39.2 M	1.34 M	219 K	1.66 M	2.35 M	3.03 M	16.3 M	33.8 M
Total Shareholders Equity	-	-	-	14.6 M	25.5 M	39.2 M	1.34 M	-	-	-	-	-	-

All numbers in CHF currency

Quarterly Balance Sheet Addex Therapeutics Ltd

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	194 K	-	-	-	259 K	-	-	-	177 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	1.48 M	-	-	-	1.95 M	-	-	-	1.82 M	-	-	-	639 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-329 M	-	-	-	-314 M	-	-	-	-301 M	-	-	-	-286 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	22.5 M	-	-	-	20.2 M	-	-	-	33 M	-	-	-	42.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	20.5 M	-	-	-	18.7 M	-	-	-	31.5 M	-	-	-	41.7 M	-	-	-	2.58 M	-	-	-	1.41 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	22.5 M	-	-	-	20.2 M	-	-	-	33 M	-	-	-	42.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	16.9 M	-	-	-	14.6 M	-	-	-	25.5 M	-	-	-	39.2 M	-	-	-	1.34 M	-	-	-	219 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in CHF currency